{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T04:02:31Z","timestamp":1772510551071,"version":"3.50.1"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,12,20]],"date-time":"2023-12-20T00:00:00Z","timestamp":1703030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,12,20]],"date-time":"2023-12-20T00:00:00Z","timestamp":1703030400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"National Health and Medical Research Council (NHMRC) of Australia","award":["APP1149987"],"award-info":[{"award-number":["APP1149987"]}]},{"name":"a seed grant for research in under-served population of low-middle income countries from The George Institute For Global Health"},{"name":"Shanghai Key Clinical Discipline","award":["shslczdzk06103"],"award-info":[{"award-number":["shslczdzk06103"]}]},{"name":"Construction Project of Key Discipline Groups of Shanghai Pudong Health Bureau","award":["PWZxq2017-08"],"award-info":[{"award-number":["PWZxq2017-08"]}]},{"name":"Pilot Program of East Hospital","award":["2017"],"award-info":[{"award-number":["2017"]}]},{"name":"Stroke and dementia special fund of Shanghai Science and Technology Development Foundation"},{"name":"Clinical Plateau Discipline Construction Project of Shanghai Pudong New Area Health Committee","award":["PWYgy2021-05"],"award-info":[{"award-number":["PWYgy2021-05"]}]},{"name":"funding of the First Affiliated Hospital of Chengdu Medical College"},{"name":"the funding of Chengdu Medical College"},{"name":"the International Cooperation Project of Chengdu Science and Technology Bureau","award":["2020-GH02-00057-HZ"],"award-info":[{"award-number":["2020-GH02-00057-HZ"]}]},{"name":"the funding of Sichuan Science and Technology Program","award":["2021YFS0376"],"award-info":[{"award-number":["2021YFS0376"]}]},{"name":"Key R&D Project of Science & Technology Department of Sichuan Province"},{"name":"Takeda China"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background and aims<\/jats:title>\n                <jats:p>Uncertainty persists over the effects of blood pressure (BP) lowering in acute stroke. The INTEnsive ambulance-delivered blood pressure Reduction in hyper-Acute stroke Trial (INTERACT4) aims to determine efficacy and safety of hyperacute intensive BP lowering in patients with suspected acute stroke. Given concerns over the safety of this treatment in the pre-hospital setting, particularly in relation to patients with intracerebral hemorrhage, we provide an update on progress of the study and profile of participants to date.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>INTERACT4 is an ongoing multicentre, ambulance-delivered, randomized, open-label, blinded endpoint trial of pre-hospital BP lowering in patients with suspected acute stroke and elevated BP in China. Patients are randomized via a mobile phone digital system to intensive (target systolic BP [SBP] &lt;140mmHg within 30 min) or guideline-recommended BP management. Primary outcome is an ordinal analysis of the full range of scores on the modified Rankin scale scores at 90 days.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Between March 2020 and April 2023, 2053 patients (mean age 70 years, female 39%) were recruited with a mean BP 178\/98 mmHg in whom 45% have a diagnosis of primary intracerebral hemorrhage upon arrival at hospital. At the time of presentation to hospital, the mean SBP was 160 and 170mmHg in the intensive and control groups (\u039410 mmHg), respectively. The independent data and safety monitoring board has not identified any safety concerns and recommended continuation of the trial. The sample size was reduced from 3116 to 2320 after meetings in August 2022 as the stroke mimic rate was persistently lower than initially estimated (6% vs 30%). The study is expected to be completed in late 2023 and the results announced in May 2024.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>INTERACT4 is on track to provide reliable evidence of the effectiveness of ambulance-delivered intensive BP lowering in patients with suspected acute stroke.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Trial registration<\/jats:title>\n                <jats:p>ClinicalTrials.gov <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03790800\">NCT03790800<\/jats:ext-link>; registered on 2 January 2019. Chinese Trial Registry <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/www.chictr.org.cn\/showproj.html?proj=34399\">ChCTR1900020534<\/jats:ext-link>, registered on 7 January 2019.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13063-023-07861-5","type":"journal-article","created":{"date-parts":[[2023,12,20]],"date-time":"2023-12-20T09:02:34Z","timestamp":1703062954000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Update on the INTEnsive ambulance-delivered blood pressure Reduction in hyper-ACute stroke Trial (INTERACT4): progress and baseline features in 2053 participants"],"prefix":"10.1186","volume":"24","author":[{"given":"Chen","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yapeng","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feifeng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoying","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laurent","family":"Billot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yiija","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hueiming","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Si","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Menglu","family":"Ouyang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunfang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hisatomi","family":"Arima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip M.","family":"Bath","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gary A.","family":"Ford","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thompson","family":"Robinson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Else Charlotte","family":"Sandset","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey L.","family":"Saver","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nikola","family":"Sprigg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H. Bart","family":"van der Worp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lili","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gang","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7248-4863","authenticated-orcid":false,"given":"Craig S.","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"for the INTERACT4 Investigators","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,12,20]]},"reference":[{"key":"7861_CR1","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1161\/STROKEAHA.121.036143","volume":"53","author":"PM Bath","year":"2022","unstructured":"Bath PM, Song L, Silva GS, Mistry E, Petersen N, Tsivgoulis G, et al. Blood pressure management for ischemic stroke in the first 24 hours. Stroke. 2022;53:1074\u201384.","journal-title":"Stroke"},{"key":"7861_CR2","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1161\/STROKEAHA.121.036139","volume":"53","author":"JS Minhas","year":"2022","unstructured":"Minhas JS, Moullaali TJ, Rinkel GJE, Anderson CS. Blood pressure management after intracerebral and subarachnoid hemorrhage: the knowns and known unknowns. Stroke. 2022;53:1065\u201373.","journal-title":"Stroke"},{"key":"7861_CR3","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1016\/S0140-6736(19)30194-1","volume":"393","author":"RIGHT-2 Investigators","year":"2019","unstructured":"RIGHT-2 Investigators. Prehospital transdermal glyceryl trinitrate in patients with ultra-acute presumed stroke (RIGHT-2): an ambulance-based, randomised, sham-controlled, blinded, phase 3 trial. Lancet. 2019;393:1009\u201320.","journal-title":"Lancet"},{"key":"7861_CR4","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/S1474-4422(22)00333-7","volume":"21","author":"SA van den Berg","year":"2022","unstructured":"van den Berg SA, Uniken Venema SM, Reinink H, Hofmeijer J, Schonewille WJ, Miedema I, et al. Prehospital transdermal glyceryl trinitrate in patients with presumed acute stroke (MR ASAP): an ambulance-based, multicentre, randomised, open-label, blinded endpoint, phase 3 trial. Lancet Neurol. 2022;21:971\u201381.","journal-title":"Lancet Neurol"},{"key":"7861_CR5","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1016\/S0140-6736(22)01882-7","volume":"400","author":"P Yang","year":"2022","unstructured":"Yang P, Song L, Zhang Y, Zhang X, Chen X, Li Y, et al. Intensive blood pressure control after endovascular thrombectomy for acute ischaemic stroke (ENCHANTED2\/MT): a multicentre, open-label, blinded-endpoint, randomised controlled trial. Lancet. 2022;400:1585\u201396.","journal-title":"Lancet"},{"key":"7861_CR6","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1186\/s13063-021-05860-y","volume":"22","author":"L Song","year":"2021","unstructured":"Song L, Chen C, Chen X, Guo Y, Liu F, Lin Y, et al. INTEnsive ambulance-delivered blood pressure Reduction in hyper-ACute stroke Trial (INTERACT4): study protocol for a randomized controlled trial. Trials. 2021;22:885.","journal-title":"Trials"},{"key":"7861_CR7","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1161\/01.STR.0000196957.55928.ab","volume":"37","author":"JL Saver","year":"2006","unstructured":"Saver JL. Time is brain--quantified. Stroke. 2006;37:263\u20136.","journal-title":"Stroke"},{"issue":"11","key":"7861_CR8","doi-asserted-by":"publisher","first-page":"3120","DOI":"10.1161\/STROKEAHA.113.001301","volume":"44","author":"S Ankolekar","year":"2013","unstructured":"Ankolekar S, Fuller M, Cross I, Renton C, Cox P, Sprigg N, et al. Feasibility of an ambulance-based stroke trial, and safety of glyceryl trinitrate in ultra-acute stroke: the rapid intervention with glyceryl trinitrate in Hypertensive Stroke Trial (RIGHT, ISRCTN66434824). Stroke. 2013;44(11):3120\u20138.","journal-title":"Stroke"},{"key":"7861_CR9","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1056\/NEJMoa1408827","volume":"372","author":"JL Saver","year":"2015","unstructured":"Saver JL, Starkman S, Eckstein M, Stratton SJ, Pratt FD, Hamilton S, et al. Prehospital use of magnesium sulfate as neuroprotection in acute stroke. N Engl J Med. 2015;372:528\u201336.","journal-title":"N Engl J Med"},{"key":"7861_CR10","doi-asserted-by":"crossref","unstructured":"Ma L, Hu X, Song L, Chen X, Ouyang M, Billot L, et al. The third Intensive Care Bundle with Blood Pressure Reduction in Acute Cerebral Haemorrhage Trial (INTERACT3): an international, stepped wedge cluster randomised controlled trial. Lancet. 2023;402(10395):27\u201340.","DOI":"10.1016\/S0140-6736(23)00806-1"},{"key":"7861_CR11","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1002\/ana.25793","volume":"88","author":"Q Li","year":"2020","unstructured":"Li Q, Warren AD, Qureshi AI, Morotti A, Falcone GJ, Sheth KN, et al. Ultra-early blood pressure reduction attenuates hematoma growth and improves outcome in intracerebral hemorrhage. Ann Neurol. 2020;88:388\u201395.","journal-title":"Ann Neurol"},{"key":"7861_CR12","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1136\/jnnp-2021-327195","volume":"93","author":"TJ Moullaali","year":"2021","unstructured":"Moullaali TJ, Wang X, Sandset EC, Woodhouse LJ, Law ZK, Arima H, et al. Early lowering of blood pressure after acute intracerebral haemorrhage: a systematic review and meta-analysis of individual patient data. J Neurol Neurosurg Psychiatry. 2021;93:6\u201313.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"7861_CR13","doi-asserted-by":"publisher","first-page":"e2824","DOI":"10.1212\/WNL.0000000000011885","volume":"96","author":"RG Nogueira","year":"2021","unstructured":"Nogueira RG, Qureshi MM, Abdalkader M, Martins SO, Yamagami H, Qiu Z, et al. Global impact of COVID-19 on stroke care and IV thrombolysis. Neurology. 2021;96:e2824\u2013e38.","journal-title":"Neurology"},{"key":"7861_CR14","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1177\/1747493021991652","volume":"16","author":"RG Nogueira","year":"2021","unstructured":"Nogueira RG, Abdalkader M, Qureshi MM, Frankel MR, Mansour OY, Yamagami H, et al. Global impact of COVID-19 on stroke care. Int J Stroke. 2021;16:573\u201384.","journal-title":"Int J Stroke"}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-023-07861-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13063-023-07861-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-023-07861-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,20]],"date-time":"2023-12-20T09:05:34Z","timestamp":1703063134000},"score":1,"resource":{"primary":{"URL":"https:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/s13063-023-07861-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,20]]},"references-count":14,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["7861"],"URL":"https:\/\/doi.org\/10.1186\/s13063-023-07861-5","relation":{},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,20]]},"assertion":[{"value":"6 June 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 December 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 December 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Each participating site must obtain written approval(s) from their hospital research ethics committee (EC) (e.g., Ethics Committee of Shanghai East Hospital [2019] Research Review 003), and any other relevant regional or national body, before patient recruitment commences. Brief (limited) informed consent in ambulance (or waiver of consent if approved by the EC) followed by consent for use of medical data and follow-up of patients obtained in hospital from all participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"CSA and LS declare receipt of grant funding and lecture fee from Takeda in China. PMB is Stroke Association Professor of Stroke Medicine and Emeritus NIHR Senior Investigator; he declares honoraria from DiaMedica, Moleac, and Phagenesis. TGR is an NIHR Senior Investigator. The other authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"817"}}